Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorial

Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?

Free

Authors

Guy G Brusselle Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium Department of Epidemiology and Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles

Correspondence to Guy G Brusselle, Department of Respiratory Medicine, Ghent University Hospital, Ghent 9000, Belgium; guy.brusselle{at}ugent.be

Citation

Brusselle GG

Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?

Thorax 2015;70:401-403.

Publication history

Accepted March 20, 2015
First published April 13, 2015.

Online issue publication

April 13, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions